Indeed, we observed an increase in LIF immunostaining in healthy subjects progressing from the proliferative to the secretory phase, but this was not witnessed in adenomyosis, where the stromal LIF expression was significantly weaker than that in healthy endometrium. The gene discussed is LIF; the disease is adenomyosis.